Anterix (NASDAQ:ATEX - Get Free Report) is projected to release its Q4 2025 earnings data after the market closes on Tuesday, June 24th. Analysts expect Anterix to post earnings of ($0.43) per share and revenue of $1.71 million for the quarter.
Anterix Stock Up 3.8%
Shares of Anterix stock opened at $27.97 on Tuesday. The firm has a market cap of $519.88 million, a price-to-earnings ratio of -17.16 and a beta of 0.88. The business has a 50-day moving average price of $29.10 and a 200-day moving average price of $32.20. Anterix has a twelve month low of $25.32 and a twelve month high of $42.91.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC lifted its holdings in shares of Anterix by 16.9% in the 1st quarter. AQR Capital Management LLC now owns 11,489 shares of the company's stock valued at $420,000 after acquiring an additional 1,659 shares during the last quarter. Millennium Management LLC lifted its stake in Anterix by 50.6% in the first quarter. Millennium Management LLC now owns 116,473 shares of the company's stock worth $4,263,000 after purchasing an additional 39,143 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of Anterix by 17.7% during the first quarter. Goldman Sachs Group Inc. now owns 124,706 shares of the company's stock worth $4,564,000 after acquiring an additional 18,771 shares during the period. Institutional investors own 87.67% of the company's stock.
Anterix Company Profile
(
Get Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
